Skip to content
10-Q/A

Quarterly Report

Eastgate Biotech Corp

0001563228-18-000018

← back to feed
Filed
Aug 17, 2018 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Aug 16, 2018 974.78M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 −$121.48K
Operating Cash Flow Q1 2017 · Mar 31, 2016 −$103.5K
Current Liabilities Q1 2017 · Mar 31, 2017 $4.89M
Current Liabilities Q1 2017 · Dec 31, 2016 $4.58M
Total Liabilities Q1 2017 · Mar 31, 2017 $4.93M
Total Liabilities Q1 2017 · Dec 31, 2016 $4.62M
Current Assets Q1 2017 · Mar 31, 2017 $9.35K
Total Assets Q1 2017 · Mar 31, 2017 $9.35K
Sga Expense Q1 2017 · Mar 31, 2017 $635.94K
Rd Expense Q1 2017 · Mar 31, 2017 $175.99K
Net Income Q1 2017 · Mar 31, 2017 −$952.11K